ManishMongaMD

Oncology • Wheeling, WV

Assistant Professor, Medicine, West Virginia University SOM

Join to view full profile

Are you Dr. Monga?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 60 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
20 Medical Park
Suite 202
Wheeling, WV 26003
Phone+1 304-243-6442

Fax+1 304-243-3715
Is this information wrong?

Summary

Dr. Manish Monga, MD is an oncologist in Wheeling, West Virginia. He is currently licensed to practice medicine in West Virginia and Ohio. He is affiliated with West Virginia University Hospitals and is an Assistant Professor at West Virginia University SOM.

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
Cook County Health and Hospitals SystemResidency, Internal Medicine, 1996 - 1999
Maulana Azad Medical CollegeClass of 1994

Certifications & Licensure

WV State Medical License 2002 - 2019
OH State Medical License 2007 - 2012

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
Completed
Phase 3
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
Active, not recruiting
Phase 3
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage Start of enrollment: 2009 Jul 16
Completed
Phase 2
Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Start of enrollment: 2009 Nov 01
Active, not recruiting
Phase 3
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma Start of enrollment: 2010 Apr 01
Completed
Phase 2
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
Completed
Phase 3
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Start of enrollment: 2010 Oct 25
Completed
Phase 3
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
Completed
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer Start of enrollment: 2012 Sep 28
Completed
Phase 1, Phase 2
1% Topical Pimecrolimus Cream for the Treatment of the Rash Associated With ERBITUX Start of enrollment: 2012 Feb 01
Terminated
Phase 2
Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2014 Jan 24
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

53 citations
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study.
Arlene O Siefker-Radtke, Andrea Necchi, Se Hoon Park, Jesús García-Donas, Robert A Huddart, Earle F Burgess, Mark T Fleming, Arash Rezazadeh Kalebasty, Begoña Mellado,...> ;The Lancet. Oncology. 2022 Feb 1
56 citations
CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer
Maura L. Gillison, George R. Blumenschein, Jérôme Fayette, Joël Guigay, A. Dimitrios Colevas, Lisa Licitra, Kevin J. Harrington, Stefan Kasper, Everett E. Vokes, Carol...> ;The Oncologist. 2018 Sep 1
364 citations
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3...
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,...> ;The Lancet. Oncology. 2017 Dec 1
68 citations
A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A suban...
Naomi Kiyota, Yasuhisa Hasegawa, Shunji Takahashi, Tomoya Yokota, Chia Jui Yen, Shigemichi Iwae, Yasushi Shimizu, Ruey Long Hong, Masahiro Goto, Jin Hyoung Kang, Wing ...> ;Oral Oncology. 2017 Oct 1
260 citations
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): healt...
Kevin J. Harrington, Robert L. Ferris, George R. Blumenschein, A. Dimitrios Colevas, Jérôme Fayette, Lisa Licitra, Stefan Kasper, Caroline Even, Everett E. Vokes, Fran...> ;The Lancet. Oncology. 2017 Aug 1
2589 citations
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
Robert L. Ferris, George R. Blumenschein, Jérôme Fayette, Joël Guigay, A. Dimitrios Colevas, Lisa Licitra, Kevin J. Harrington, Stefan Kasper, Everett E. Vokes, Caroli...> ;The New England Journal of Medicine. 2016 Oct 8
2 citations
Definitive Upfront Stereotactic Ablative Radiotherapy Combined with Image-Guided, Intensity Modulated Radiotherapy (IG-IMRT) or IG-IMRT Alone for Locally Advanced Non-...
Alexander Chi, Sijin Wen, Manish Monga, Xiaoqing He, Yon Rojanasakul, William Tse, Scot C. Remick> ;Plos One. 2016 Sep 9
55 citations
Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research...
Chandra P. Belani, Suzanne E. Dahlberg, Charles M. Rudin, Martin Fleisher, Helen X. Chen, Naoko Takebe, Mario R. Velasco, William Tester, Keren Sturtz, Christine L. Ha...> ;Cancer. 2016 Aug 1
10 citations
Quantification of Anaplastic Lymphoma Kinase Protein Expression in Non–Small Cell Lung Cancer Tissues from Patients Treated with Crizotinib
Todd Hembrough, Wei-Li Liao, Christopher P. Hartley, Patrick C. Ma, Vamsidhar Velcheti, Christopher Lanigan, Sheeno Thyparambil, Eunkyung An, Manish Monga, David B. Kr...> ;Clinical Chemistry. 2016 Jan 1
1 citations
Sorafenib and thyroid cancer
Chandler H. Park, Jessica Perini, Roger W. Farmer, Tanya Fancy, Manish Monga, Scot C. Remick> ;Expert Review of Endocrinology & Metabolism. 2014 Oct 21
14 citations
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms
William D. Figg, Manish Monga, Donna Headlee, Avni A. Shah, Cindy H. Chau, Cody J. Peer, Richard Messman, Yusri A. Elsayed, Anthony J. Murgo, Giovanni Melillo, Qin C. ...> ;Cancer Chemotherapy and Pharmacology. 2014 Sep 3
9 citations
Strategies of Dose Escalation in the Treatment of Locally Advanced Non-Small Cell Lung Cancer: Image Guidance and Beyond
Alexander Chi, Nam P. Nguyen, James S. Welsh, William Tse, Manish Monga, Olusola Oduntan, John S. Rogers, Scot C. Remick, David Gius> ;Frontiers in Oncology. 2014 Jun 20
7 citations
Breaking and entering into the CNS: clues from solid tumor and nonmalignant models with relevance to hematopoietic malignancies.
Soumit Basu, Scot C. Remick, Manish Monga, Laura F. Gibson> ;Clinical & Experimental Metastasis. 2014 Feb 1
1 citations
Targeted treatment for melanoma.
Manish Monga, Jame Abraham> ;Expert Review of Anticancer Therapy. 2012 Sep 1
4 citations
Building a Statewide Clinical Trials Network for Cancer Care in West Virginia
Jame Abraham, James Keresztury, John Azar, Manish Monga, Timothy Bowers, Mathew Page Jones, Maria Tria Tirona, Jondavid Pollock, Craig Coonley, Steven J. Jubelirer, Ja...> ;The West Virginia Medical Journal. 2009 Oct 1
331 citations
Phase I and Pharmacokinetic Study of MS-275, a Histone Deacetylase Inhibitor, in Patients With Advanced and Refractory Solid Tumors or Lymphoma
Qin C. Ryan, Donna Headlee, Milin Acharya, Alex Sparreboom, Jane B. Trepel, Joseph Z. Ye, William D. Figg, Kyunghwa Hwang, Eun Joo Chung, Anthony J. Murgo, Giovanni Me...> ;Journal of Clinical Oncology. 2005 Jun 10
70 citations
Signal Transduction–Directed Cancer Treatments*
Edward A. Sausville, Yusri A. Elsayed, Manish Monga, George Kim> ;Annual Review of Pharmacology and Toxicology. 2003 Nov 28
Developmental therapeutics program at the NCI: molecular target and drug discovery process.
Monga M, Sausville EA> ;Leukemia. 2002-04-01
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

West Virginia University HospitalsMorgantown, West Virginia